803 858 2121
Free call
-
Narrow Your Focus to Prevent Overanalysis
- 1 February 2022
- Posted by: cobondsinvestments.com
- Category: Franchising
No Comments
What is this highly valuable asset? Its own people. Says Morgan Fraud, the author of The Thinking Corporation, “Given that we are all capable of contributing new ideas, the question becomes how do you successfully generate, capture, process and implement ideas?”
-
Three Social Media Hacks for the Busy Entrepreneur
- 31 January 2022
- Posted by: cobondsinvestments.com
- Category: Innovation
The teams focused their efforts on a few of the highest-value S&OP levers in order to review the current planning process, identify gaps in the planning infrastructure and analytically understand demand and supply variability.
-
Stick with Your Concept but Do Your Homework
- 29 January 2022
- Posted by: cobondsinvestments.com
- Category: Economics
With hundreds of medications in the market, Pharm Ltd. needed a proper method to predict and manage their inventory. Using a mean absolute percentage analysis (MAPE), the teams defined appropriate levels for raw materials and finished products by mapping.
-
Within the construction industry as their overdraft
- 28 January 2022
- Posted by: cobondsinvestments.com
- Category: Funding trends
Many businesses, large and small, have a huge source of great ideas that can help them improve, innovate, and grow, and yet so many of these companies never think of using this amazing corporate asset. What is this highly valuable asset? Its own people.
-
Retail banks wake up to digital lending this year
- 24 January 2022
- Posted by: cobondsinvestments.com
- Category: Franchising
The effort vastly improved the company’s planning and execution functions, created and implemented a new stock policy that accounted for specific SKUs and key variables, streamlined the order preparation process and reduced distribution transport times.
-
A digital prescription for the pharma industry
- 22 January 2022
- Posted by: cobondsinvestments.com
- Category: Business plans
Supported by a robust sales force and tight cost controls, Pharm Ltd. experienced sustained double-digit growth over a number of years, only to find that their supply chain struggled to keep pace. In particular, the initial state of the company’s sales.